Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BUTYL ANTHRANILATE is a benzoate ester derived from the formal condensation of anthranilic acid and butanol. It is a dark brown liquid that is insoluble in water and has a sweet, faint, fruit (plum, petigrain) note. Found in several fruit species, it is used as a flavoring and fragrance agent and also exhibits insect repellent properties.

7756-96-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7756-96-9 Structure
  • Basic information

    1. Product Name: BUTYL ANTHRANILATE
    2. Synonyms: 2-amino-benzoicacibutylester;2-aminobenzoicacidbutylester;anthranilicacid,butylester;ANTHRANILIC ACID N-BUTYL ESTER;FEMA 2181;BUTYL ANTHRANILATE;BUTYL 2-AMINOBENZOATE;BUTYL O-AMINOBENZOATE
    3. CAS NO:7756-96-9
    4. Molecular Formula: C11H15NO2
    5. Molecular Weight: 193.24
    6. EINECS: 231-816-7
    7. Product Categories: A-B;Alphabetical Listings;Flavors and Fragrances
    8. Mol File: 7756-96-9.mol
    9. Article Data: 11
  • Chemical Properties

    1. Melting Point: <0 °C
    2. Boiling Point: 303 °C(lit.)
    3. Flash Point: >230 °F
    4. Appearance: dark brown liquid
    5. Density: 1.06 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 0.00138mmHg at 25°C
    7. Refractive Index: n20/D 1.545(lit.)
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 2.17±0.10(Predicted)
    11. Stability: Stability Air and light sensitive. Incompatible with alkalies, acids, strong oxidizing agents.
    12. CAS DataBase Reference: BUTYL ANTHRANILATE(CAS DataBase Reference)
    13. NIST Chemistry Reference: BUTYL ANTHRANILATE(7756-96-9)
    14. EPA Substance Registry System: BUTYL ANTHRANILATE(7756-96-9)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 22-36/37/38
    3. Safety Statements: 26
    4. WGK Germany: 2
    5. RTECS: DG1527000
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 7756-96-9(Hazardous Substances Data)

7756-96-9 Usage

Uses

Used in Flavor and Fragrance Industry:
BUTYL ANTHRANILATE is used as a flavoring agent for its sweet, faint, fruit (plum, petigrain) note, adding a floral, green, fruity, sweet citrus, and waxy character to food products and beverages.
Used in Perfumery:
BUTYL ANTHRANILATE is used as a fragrance agent to impart a floral, green, fruity, sweet citrus, and waxy character to perfumes and other scented products.
Used in Insect Repellent Industry:
BUTYL ANTHRANILATE is used as an insect repellent due to its natural properties that help ward off insects.
Used in Natural Products Industry:
BUTYL ANTHRANILATE is used in natural products such as essential oils, where it is reported to be present in peppermint oil from Brazil, Achillea ageratum, tea, and apple aroma, adding to the overall scent profile of these products.

Preparation

Prepared by transesterification of methyl anthranilate (methyl 2-aminobenzoate) with n-butyl alcohol in the presence of HCl.

Air & Water Reactions

Sensitive to air and light. Insoluble in water. BUTYL ANTHRANILATE will hydrolyze under high and low pH conditions. .

Reactivity Profile

BUTYL ANTHRANILATE is an aminophenyl ester derivative. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides. Esters react with acids to liberate heat along with alcohols and acids. Strong oxidizing acids may cause a vigorous reaction that is sufficiently exothermic to ignite the reaction products. Heat is also generated by the interaction of esters with caustic solutions. Flammable hydrogen is generated by mixing esters with alkali metals and hydrides.

Fire Hazard

Flash point data for BUTYL ANTHRANILATE are not available. BUTYL ANTHRANILATE is probably combustible.

Metabolism

Esters of benzoic acid are presumably either hydrolysed and then metabolized according to the normal pattern for the alcohol and acid produced, or possibly in some cases the ring may be hydroxylated and the product excreted as a glucuronide or sulphate ester . H-Butanol and isobutanol are rapidly oxidized in vivo, presumably to the aldehyde and acid ; only small amounts were excreted by rabbits as the glucuronic acid conjugates

Check Digit Verification of cas no

The CAS Registry Mumber 7756-96-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,5 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 7756-96:
(6*7)+(5*7)+(4*5)+(3*6)+(2*9)+(1*6)=139
139 % 10 = 9
So 7756-96-9 is a valid CAS Registry Number.

7756-96-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (75031)  Butylanthranilate  analytical standard

  • 7756-96-9

  • 75031-1ML

  • 537.03CNY

  • Detail

7756-96-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name butyl anthranilate

1.2 Other means of identification

Product number -
Other names Butyl Anthranilate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7756-96-9 SDS

7756-96-9Synthetic route

2-(sulfinylamino)benzoyl chloride
64001-48-5

2-(sulfinylamino)benzoyl chloride

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
for 1h;99.4%
isatoic anhydride
118-48-9

isatoic anhydride

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
With sodium hydroxide at 85℃;78%
With sodium hydride In mineral oil for 2h; Reflux; Inert atmosphere;56%
With sodium Heating;40.3%
2-nitro-benzaldehyde
552-89-6

2-nitro-benzaldehyde

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
With dmap; ethyl 2-cyanoacetate at 20℃; for 5h; chemoselective reaction;70%
2-Nitrobenzyl alcohol
612-25-9

2-Nitrobenzyl alcohol

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
With caesium carbonate at 100℃; for 16h; Inert atmosphere; Schlenk technique;48%
anthranilic acid
118-92-3

anthranilic acid

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
With thionyl chloride for 2h; Heating;39%
With sulfuric acid Reflux;29.13%
With phosphate buffer; Porcine Pancreas Lipase In hexane; chloroform for 72h; pH=7.0;4.5%
Stage #1: anthranilic acid; butan-1-ol With sulfuric acid for 2h; Reflux;
Stage #2: With ammonium hydroxide In water
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
2-carbomethoxyaniline
134-20-3

2-carbomethoxyaniline

butan-1-ol
71-36-3

butan-1-ol

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

Conditions
ConditionsYield
With hydrogenchloride
mesityl(3-(pentafluoro-λ6-sulfanyl)phenyl)iodonium trifluoromethanesulfonate

mesityl(3-(pentafluoro-λ6-sulfanyl)phenyl)iodonium trifluoromethanesulfonate

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

butyl 2-((3-(pentafluoro-λ6-sulfanyl)phenyl)amino)benzoate

butyl 2-((3-(pentafluoro-λ6-sulfanyl)phenyl)amino)benzoate

Conditions
ConditionsYield
With copper In 1-methyl-pyrrolidin-2-one at 80℃; for 12h; Inert atmosphere;97%
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

diisopropyl-carbodiimide
693-13-0

diisopropyl-carbodiimide

3-isopropyl-2-(isopropylamino)quinazolin-4(3H)-one
14333-75-6

3-isopropyl-2-(isopropylamino)quinazolin-4(3H)-one

Conditions
ConditionsYield
With tris(bis(trimethylsilyl)amido)lanthanum(III) In neat (no solvent) at 100℃; for 12h; Schlenk technique; Inert atmosphere;93%
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

n-butyl 2-azidobenzoate
1415326-10-1

n-butyl 2-azidobenzoate

Conditions
ConditionsYield
Stage #1: n-butyl anthranilate With hydrogenchloride; sodium nitrite In water at 0 - 5℃; for 0.666667h;
Stage #2: With sodium azide In water for 0.5h;
75%
Stage #1: n-butyl anthranilate With hydrogenchloride; sodium nitrite In water; acetone at 0℃;
Stage #2: With sodium azide; sodium acetate In water; acetone at 5℃;
ortho-bromophenylacetic acid
18698-97-0

ortho-bromophenylacetic acid

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

n-butyl 2-(2-(2-bromophenyl)acetamido)benzoate
1345540-38-6

n-butyl 2-(2-(2-bromophenyl)acetamido)benzoate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 24h;74%
dibutyl chlorophosphite
4124-92-9

dibutyl chlorophosphite

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

dibutyl phosphoramidite
82754-10-7

dibutyl phosphoramidite

Conditions
ConditionsYield
With triethylamine In benzene for 2h; Ambient temperature;71%
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

(2-fluorophenyl)acetic acid
451-82-1

(2-fluorophenyl)acetic acid

n-butyl 2-(2-(2-fluorophenyl)acetamido)benzoate
1345540-34-2

n-butyl 2-(2-(2-fluorophenyl)acetamido)benzoate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 24h;62%
2'-chloro-benzeneacetic acid
2444-36-2

2'-chloro-benzeneacetic acid

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

n-butyl 2-(2-(2-chlorophenyl)acetamido)benzoate
1345540-36-4

n-butyl 2-(2-(2-chlorophenyl)acetamido)benzoate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 24h;61%
diethyl-phosphoramidous acid dibutyl ester
41075-90-5

diethyl-phosphoramidous acid dibutyl ester

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

dibutyl phosphoramidite
82754-10-7

dibutyl phosphoramidite

Conditions
ConditionsYield
at 115℃;60.2%
embelin
550-24-3

embelin

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

2-(4-Hydroxy-3,6-dioxo-5-undecyl-cyclohexa-1,4-dienylamino)-benzoic acid butyl ester
101689-27-4

2-(4-Hydroxy-3,6-dioxo-5-undecyl-cyclohexa-1,4-dienylamino)-benzoic acid butyl ester

Conditions
ConditionsYield
With acetic acid at 100℃;58%
diisopropyl phosphorochloridite
41662-51-5

diisopropyl phosphorochloridite

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

2-(Diisopropoxy-phosphanylamino)-benzoic acid butyl ester
82754-08-3

2-(Diisopropoxy-phosphanylamino)-benzoic acid butyl ester

Conditions
ConditionsYield
With triethylamine In benzene for 2h; Ambient temperature;48.3%
formaldehyd
50-00-0

formaldehyd

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

butyl 2-(methylamino)benzoate
15236-34-7

butyl 2-(methylamino)benzoate

Conditions
ConditionsYield
With acetic acid; zinc In 1,4-dioxane; water at 50 - 60℃; for 6h;23%
2,5-dimethoxy-3-undecyl-1,4-benzoquinone
14065-83-9

2,5-dimethoxy-3-undecyl-1,4-benzoquinone

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

A

2-(4-Methoxy-3,6-dioxo-5-undecyl-cyclohexa-1,4-dienylamino)-benzoic acid butyl ester
101689-48-9

2-(4-Methoxy-3,6-dioxo-5-undecyl-cyclohexa-1,4-dienylamino)-benzoic acid butyl ester

B

C39H52N2O6
101689-39-8

C39H52N2O6

Conditions
ConditionsYield
With acetic acidA 14%
B 20%
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

chloroacetyl chloride
79-04-9

chloroacetyl chloride

N-chloroacetyl-anthranilic acid butyl ester
100614-29-7

N-chloroacetyl-anthranilic acid butyl ester

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

3,4-dimethoxybenzoic acid chloride
3535-37-3

3,4-dimethoxybenzoic acid chloride

2-(3,4-Dimethoxy-benzoylamino)-benzoic acid butyl ester
67836-65-1

2-(3,4-Dimethoxy-benzoylamino)-benzoic acid butyl ester

Conditions
ConditionsYield
With triethylamine In benzene for 3h; Ambient temperature;
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

2-Butoxycarbonyl-benzenediazonium; chloride

2-Butoxycarbonyl-benzenediazonium; chloride

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite In water at 5℃;
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

dimedone
126-81-8

dimedone

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

2-(2-butyloxycarbonylphenyl)aminomethylidene-5,5-dimethylcyclohexane-1,3-dione

2-(2-butyloxycarbonylphenyl)aminomethylidene-5,5-dimethylcyclohexane-1,3-dione

Conditions
ConditionsYield
at 125 - 130℃; for 0.166667h;
formic acid
64-18-6

formic acid

n-butyl anthranilate
7756-96-9

n-butyl anthranilate

2-formylamino-benzoic acid butyl ester
360795-64-8

2-formylamino-benzoic acid butyl ester

Conditions
ConditionsYield
In toluene Heating;
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

2-isocyano-benzoic acid butyl ester
360795-69-3

2-isocyano-benzoic acid butyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene / Heating
2: POCl3; Et3N / tetrahydrofuran / 0 °C
View Scheme
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

n-butyl 4-hydroxy-3-quinolinecarboxylate

n-butyl 4-hydroxy-3-quinolinecarboxylate

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: toluene / Heating
2: POCl3; Et3N / tetrahydrofuran / 0 °C
3: magnesium bis(diisopropylamide) / diethyl ether / 0 °C
4: magnesium bis(diisopropylamide) / diethyl ether / 2 h
View Scheme
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

3-(2-isocyano-phenyl)-3-oxo-propionic acid butyl ester

3-(2-isocyano-phenyl)-3-oxo-propionic acid butyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: toluene / Heating
2: POCl3; Et3N / tetrahydrofuran / 0 °C
3: magnesium bis(diisopropylamide) / diethyl ether / 0 °C
View Scheme
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

C17H19N3O2
180335-19-7

C17H19N3O2

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaNO2, HCl / H2O / 5 °C
2: NH4OAc / H2O
View Scheme
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

C17H28NO4PSe
82754-13-0

C17H28NO4PSe

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 48.3 percent / triethylamine / benzene / 2 h / Ambient temperature
2: 46.8 percent / selenium
View Scheme
n-butyl anthranilate
7756-96-9

n-butyl anthranilate

O,O-dibutyl phosphoramidothioate
82754-15-2

O,O-dibutyl phosphoramidothioate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 71 percent / triethylamine / benzene / 2 h / Ambient temperature
2: 84.6 percent / sulfur / 60 °C
View Scheme
Multi-step reaction with 2 steps
1: 60.2 percent / 115 °C
2: 84.6 percent / sulfur / 60 °C
View Scheme

7756-96-9Relevant articles and documents

Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists

Roell, Daniela,R?sler, Thomas W.,Hessenkemper, Wiebke,Kraft, Florian,Hauschild, Monique,Bartsch, Sophie,Abraham, Tsion E.,Houtsmuller, Adriaan B.,Matusch, Rudolf,van Royen, Martin E.,Baniahmad, Aria

, p. 59 - 70 (2019/02/01)

Androgen receptor (AR) antagonists are used for hormone therapy of prostate cancer (PCa). However resistance to the treatment occurs eventually. One possible reason is the occurrence of AR mutations that prevent inhibition of AR-mediated transactivation by antagonists. To offer in future more options to inhibit AR signaling, novel chemical lead structures for new AR antagonists would be beneficial. Here we analyzed structure-activity relationships of a battery of 36 non-steroidal structural variants of methyl anthranilate including 23 synthesized compounds. We identified structural requirements that lead to more potent AR antagonists. Specific compounds inhibit the transactivation of wild-type AR as well as AR mutants that render treatment resistance to hydroxyflutamide, bicalutamide and the second-generation AR antagonist enzalutamide. This suggests a distinct mode of inhibiting the AR compared to the clinically used compounds. Competition assays suggest binding of these compounds to the AR ligand binding domain and inhibit PCa cell proliferation. Moreover, active compounds induce cellular senescence despite inhibition of AR-mediated transactivation indicating a transactivation-independent AR-pathway. In line with this, fluorescence resonance after photobleaching (FRAP) - assays reveal higher mobility of the AR in the cell nuclei. Mechanistically, fluorescence resonance energy transfer (FRET) - assays indicate that the amino-carboxy (N/C)-interaction of the AR is not affected, which is in contrast to known AR-antagonists. This suggests a mechanistically novel mode of AR-antagonism. Together, these findings indicate the identification of a novel chemical platform as a new lead structure that extends the diversity of known AR antagonists and possesses a distinct mode of antagonizing AR-function.

Transition-metal-catalyst-free synthesis of anthranilic acid derivatives by transfer hydrogenative coupling of 2-nitroaryl methanols with alcohols/amines

Zhang, Shudi,Tan, Zhenda,Xiong, Biao,Jiang, Huan Feng,Zhang, Min

supporting information, p. 531 - 535 (2018/02/07)

By using a transfer hydrogenative coupling strategy, we herein describe a new method for the efficient synthesis of anthranilic acid derivatives, a significantly important class of compounds with extensive applications in organic synthesis and the discovery of bioactive molecules, from 2-nitroaryl methanols and readily available alcohols/amines. The synthesis proceeds with the merits of no need for a transition metal catalyst, operational simplicity, broad substrate scope, good functional tolerance, and high step efficiency, which offers a useful alternative to access anthranilic acid derivatives.

Competitive homolytic and heterolytic decomposition pathways of gas-phase negative ions generated from aminobenzoate esters

Xia, Hanxue,Zhang, Yong,Pavlov, Julius,Jariwala, Freneil B.,Attygalle, Athula B.

, p. 245 - 253 (2016/03/15)

An alkyl-radical loss and an alkene loss are two competitive fragmentation pathways that deprotonated aminobenzoate esters undergo upon activation under mass spectrometric conditions. For the meta and para isomers, the alkyl-radical loss by a homolytic cleavage of the alkyl-oxygen bond of the ester moiety is the predominant fragmentation pathway, while the contribution from the alkene elimination by a heterolytic pathway is less significant. In contrast, owing to a pronounced charge-mediated ortho effect, the alkene loss becomes the predominant pathway for the ortho isomers of ethyl and higher esters. Results from isotope-labeled compounds confirmed that the alkene loss proceeds by a specific γ-hydrogen transfer mechanism that resembles the McLafferty rearrangement for radical cations. Even for the para compounds, if the alkoxide moiety bears structural motifs required for the elimination of a more stable alkene molecule, the heterolytic pathway becomes the predominant pathway. For example, in the spectrum of deprotonated 2-phenylethyl 4-aminobenzoate, m/z 136 peak is the base peak because the alkene eliminated is styrene. Owing to the fact that all deprotonated aminobenzoate esters, irrespective of the size of the alkoxy group, upon activation fragment to form an m/z 135 ion, aminobenzoate esters in mixtures can be quantified by precursor ion discovery mass spectrometric experiments.

Beyond conventional routes, an unprecedented metal-free chemoselective synthesis of anthranilate esters via a multicomponent reaction (MCR) strategy

Sarkar, Satavisha,Khan, Abu T.

supporting information, p. 12673 - 12676 (2015/08/06)

A hitherto unreported route for the synthesis of anthranilate esters is demonstrated using 2-nitrobenzaldehyde, malonitrile and an alcohol or amine via a metal and oxidant free multicomponent reaction (MCR) strategy. This process simultaneously installs an ester and urea or urethane functionality via CO and CN bond formations via concurrent oxidation of the aldehyde group and reduction of the nitro group involving an intramolecular redox process.

Synthesis, antimicrobial evaluation, ot-QSAR and mt-QSAR studies of 2-amino benzoic acid derivatives

Mahiwal, Kuldeep,Kumar, Pradeep,Narasimhan, Balasubramanian

experimental part, p. 293 - 307 (2012/09/07)

A series of 2-amino benzoic acid derivatives (1-28) were synthesized and evaluated for their in vitro antimicrobial activity against the panel of Gram positive, Gram negative bacterial and fungal strains. The results of antimicrobial studies indicated that, in general, the synthesized compounds were found to be bacteriostatic and fungistatic in action. QSAR studies performed by the development of one target and multi target models indicated that multi-target model was effective in describing the antimicrobial activity as well demonstrated the effect of structural parameters viz. LUMO, 3χv and W on antimicrobial activity of 2-amino benzoic acid derivatives. Springer Science+Business Media, LLC 2010.

Synthesis and cytotoxicity of some d-mannose click conjugates with aminobenzoic acid derivatives

Hradilová, Ludmila,Poláková, Monika,Dvo?áková, Barbora,Hajdúch, Marián,Petru?, Ladislav

, p. 1 - 6 (2013/01/15)

Two sets of new conjugates obtained from d-mannose derivatives and o-, m-, and p-substituted benzoic acid esters interconnected through a triazole ring were synthesized by Cu(I) catalyzed azide-alkyne cycloaddition. All synthesized compounds were tested for their in vitro cytotoxic activity against seven cancer cell lines with/without multidrug resistance phenotype as well as non-tumor MRC-5 and BJ fibroblasts. Butyl ester of 4-aminobenzoic acid 6c showed the highest activity among all tested compounds, however, it was active only against K562 myeloid leukemia cells. N-Glycosyltriazole conjugates, both acetylated and nonacetylated at mannose moiety, were almost completely inactive. In contrast, some of the acetylated O-glycosyl conjugates showed cytotoxic activity which was cell line dependent and strongly affected by position of benzoic acid substitution as well as a length of its ester alkyl chain; the most potent compound was acetylated mannoside conjugated with octyl ester of m-substituted benzoic acid. However, deacetylation resulting in hydrophilicity increase of the glycosides almost completely abolished their cytotoxic potency.

Anthranilic acid-based inhibitors of phosphodiesterase: Design, synthesis, and bioactive evaluation

Cheng, Yih-Dih,Hwang, Tsong-Long,Wang, Han-Hsiang,Pan, Tai-Long,Wu, Chin-Chung,Chang, Wen-Yi,Liu, Yi-Ting,Chu, Tzu-Chi,Hsieh, Pei-Wen

experimental part, p. 7113 - 7125 (2011/11/04)

Our previous studies identified two 2-benzoylaminobenzoate derivatives 1, which potently inhibited superoxide (O2-) generation induced by formyl-l-methionyl-l-leucyl-l-phenylalanine (FMLP) in human neutrophils. In an attempt to improve their activities, a series of anthranilic acid derivatives were synthesized and their anti-inflammatory effects and underlying mechanisms were investigated in human neutrophils. Of these, compounds 17, 18, 46, 49, and 50 showed the most potent inhibitory effect on FMLP-induced release of O2- in human neutrophils with IC50 values of 0.20, 0.16, 0.15, 0.06, and 0.29 μM, respectively. SAR analysis showed that the activities of most compounds were dependent on the ester chain length in the A ring. Conversely, a change in the linker between the A and B ring from amide to sulfonamide or N-methyl amide, as well as exchanges in the benzene rings (A or B rings) by isosteric replacements were unfavorable. Further studies indicated that inhibition of O2- production in human neutrophils by these anthranilic acids was associated with an elevation in cellular cAMP levels through the selective inhibition of phosphodiesterase 4. Compound 49 could be approved as a lead for the development of new drugs in the treatment of neutrophilic inflammatory diseases.

On the reaction of anthranilic acid with thionyl chloride: Iminoketene intermediate formation

Jacob, Dominic E.,Mathew, Lopez

, p. 664 - 668 (2008/09/18)

2-(Sulfinylamino) benzoyl chloride is formed on treating anthranilic acid with thionyl chloride. The formation of iminoketene intermediate from 2-(sulfinylamino) benzoyl chloride is established and the reactions carried out using the intermediate are described.

Selection of Alcohols Through Plackett-Burman Design in Lipase-Catalyzed Synthesis of Anthranilic Acid Esters

Babu, C. V. Suresh,Divakar, S.

, p. 49 - 52 (2007/10/03)

Lipase-catalyzed synthesis of esters of anthranilic acid was attempted by employing alcohols of carbon chain-length C1-C18 using Plackett-Burman experimental design. Of the alcohols employed, methanol, decanol, cetyl alcohol, and stearyl alcohols showed 99.9 percent significance. Esterification of anthranilic acid with methanol gave the highest yield at 45.6 percent. This study allows the selection of better alcohols for esterification of anthranilic acid.

An efficient general method for esterification of aromatic carboxylic acids

Hosangadi, Bhaskar D.,Dave, Rajesh H.

, p. 6375 - 6378 (2007/10/03)

Treatment of a variety of aromatic carboxylic acids with alcohols in the presence of thionyl chloride results in excellent yields of corresponding esters. This esterification system is compatible with a wide assortment of functional groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7756-96-9